MXene-Polydopamine-antiCEACAM1 Antibody Complex as a Strategy for Targeted Ablation of Melanoma.

Konieva A, Deineka V, Diedkova K, Aguilar-Ferrer D, Lyndin M, Wennemuth G, Korniienko V, Kyrylenko S, Lihachev A, Zahorodna V, Baginskiy I, Coy E, Gogotsi O, Blacha-Grzechnik A, Simka W, Kube-Golovin I, Iatsunskyi I, Pogorielov M.

Open source

DOI: 10.1021/acsami.4c08129
Published: 2024-08-07
Container: ACS Appl Mater Interfaces
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1021/acsami.4c08129,
  title = {MXene-Polydopamine-antiCEACAM1 Antibody Complex as a Strategy for Targeted Ablation of Melanoma.},
  author = {Konieva A and  Deineka V and  Diedkova K and  Aguilar-Ferrer D and  Lyndin M and  Wennemuth G and  Korniienko V and  Kyrylenko S and  Lihachev A and  Zahorodna V and  Baginskiy I and  Coy E and  Gogotsi O and  Blacha-Grzechnik A and  Simka W and  Kube-Golovin I and  Iatsunskyi I and  Pogorielov M.},
  year = {2024},
  journal = {ACS Appl Mater Interfaces},
  doi = {10.1021/acsami.4c08129},
  url = {https://doi.org/10.1021/acsami.4c08129}
}

RIS

TY  - JOUR
TI  - MXene-Polydopamine-antiCEACAM1 Antibody Complex as a Strategy for Targeted Ablation of Melanoma.
AU  - Konieva A
AU  -  Deineka V
AU  -  Diedkova K
AU  -  Aguilar-Ferrer D
AU  -  Lyndin M
AU  -  Wennemuth G
AU  -  Korniienko V
AU  -  Kyrylenko S
AU  -  Lihachev A
AU  -  Zahorodna V
AU  -  Baginskiy I
AU  -  Coy E
AU  -  Gogotsi O
AU  -  Blacha-Grzechnik A
AU  -  Simka W
AU  -  Kube-Golovin I
AU  -  Iatsunskyi I
AU  -  Pogorielov M.
PY  - 2024
JO  - ACS Appl Mater Interfaces
DO  - 10.1021/acsami.4c08129
UR  - https://doi.org/10.1021/acsami.4c08129
ER  -

APA

A, K., V, D., K, D., D, A., M, L., G, W., V, K., S, K., A, L., V, Z., I, B., E, C., O, G., A, B., W, S., I, K., I, I., & M., P. (2024). MXene-Polydopamine-antiCEACAM1 Antibody Complex as a Strategy for Targeted Ablation of Melanoma.. ACS Appl Mater Interfaces. https://doi.org/10.1021/acsami.4c08129

Source records

europe-pmc · retrieved 2026-09-25T11:41:24.633Z
hal · retrieved 2026-09-25T11:41:24.681Z